CBS2023
The 15th CBS event, CBS 2023, will feature specialized academic forums covering a wide range of topics, including Complex Coronary Intervention, Intravascular Imaging, Pulmonary Arterial Hypertension, Structural Heart Disease Intervention, Arrhythmia, Heart Failure, Hypertension, Basic Research, and Clinical Trial. The conference aims to showcase advanced medical technologies and treatment methods in the field of cardiovascular intervention, along with in-depth discussions on cutting-edge trends. It will also provide a platform for open dialogues among top experts, creating a professional, in-depth, and exciting academic experience for all participants.
Results:
Date/Time
Room
Session
Name
Role
Presentation Title
12:15 pm-12:20 pm,
Friday, December 1, 2023
Lijing Building- No.1 Meeting Room Easy depose Presise contol
Junjie Zhang Host Opening Remarks
12:20 pm-12:35 pm,
Friday, December 1, 2023
Lijing Building- No.1 Meeting Room Easy depose Presise contol
Jing Chen Speaker When and how: TAVR in traeting AR
12:40 pm-12:55 pm,
Friday, December 1, 2023
Lijing Building- No.1 Meeting Room Easy depose Presise contol
Feicheng Yu Speaker Application of VitaFlow Liberty in Pure AR
1:00 pm-1:15 pm,
Friday, December 1, 2023
Lijing Building- No.1 Meeting Room Easy depose Presise contol
Wei Xia Speaker A case of aortic regurgitation through the femoral artery after mechanical mitral valve replacement
1:20 pm-1:35 pm,
Friday, December 1, 2023
Lijing Building- No.1 Meeting Room Easy depose Presise contol
Yijiang Zhou Speaker Application of VitaFlow Liberty in severe calcification patient
12:40 pm-2:12 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Li Zhang Moderator
12:40 pm-2:12 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Lianpin Wu Moderator
12:40 pm-2:12 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Wei Chen Discussant
12:40 pm-2:12 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Hao Zhang Discussant
12:40 pm-2:12 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Faxin Ren Discussant
12:40 pm-12:45 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Junjie Zhang Host Opening Remarks
12:45 pm-1:00 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Yongjian Wu Speaker Four-years follow-up outcomes of TaurusOne regisry study and its application in challengeable AS cases
1:02 pm-1:17 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Longyan Zhang Speaker self-expanding TAVI device in pure AR patient based on STABLE principle
1:19 pm-1:34 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Wenzhi Pan Speaker Surgical strategy and single center operation experience for TAVR with poor coaxiality
1:36 pm-1:51 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Ben He Speaker Innovative GeminiOne Mitral Transcatheter Edge-to-Edge Repair design and clinical practice
1:53 pm-2:08 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Guangyuan Song Speaker Interpretation of ALIGN-AR Research Results and Early Clinical Study of Taurus Trio
2:10 pm-2:12 pm,
Friday, December 1, 2023
Caritas Hall, 1st Floor, Lijing Building Thematic Meeting
Yongjian Wu Speaker Conclusion and Session Summary
1:00 pm-2:10 pm,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅱ
Yaling Han Moderator
1:00 pm-2:10 pm,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅱ
Yong Zeng Moderator
1:00 pm-3:20 pm,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 2 Risk Stratifications and Trials
Qiguang Wang Moderator
Records:819 Pre[6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Next

http://www.cbsmd.cn Contact us by cbs@cbsmd.cn

Copyright ⓒ CBSMD Nanjing China. All rights reserved.